EP2918288
Use of TGF beta antagonists to treat infants at risk of developing bronchopulmonary dysplasia
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
3.10.2007EP published:
16.8.2017EP application number:
15154393.1
EPO information:
European Patent Register
Max expiry date:
2.10.2027
Title:
Use of TGF beta antagonists to treat infants at risk of developing bronchopulmonary dysplasia
Timeline
Today
3.10.2007EP application
16.8.2017EP Publication
Owner
Name:
Genzyme CorporationAddress:
50 Binney Street, 02142, Cambridge, MA, US
Name:
The General Hospital CorporationAddress:
Massachusetts General Hospital 55 Fruit Street, 02114, Boston, MA, US
Inventor
Name:
Streisand, James B.Address:
Cambridge, Massachusetts, US
Name:
Roberts, Jesse D.Address:
Brighton, Massachusetts, US
Priority
Number:
827933 PDate:
3.10.2006Country:
US
Classification
Categories:
A61K 39/395, A61P 11/00, C07K 16/22, A61K 45/06, A61K 39/00